PC-300 Tea Effect on Triglyceride Levels
Märksõnad
Abstraktne
Kirjeldus
It was a descriptive, prospective, longitudinal, and comparative clinical study developed at Ciprés Grupo Médico S.C. (CGM), Toluca, Mexico, from January 2014 to December 2014.
Patients with hypertriglyceridemia were invited to participate in the study. Voluntary subjects were assigned sequentially into two treatment groups: 1) fibrate (bezafibrate) 200 mg/day, and 2) PC-300 tea, one cup half an hour before eating.
Patients were measured (m) and weighed (kg) (Obi, México). Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Blood pressure was measured with a calibrated sphygmomanometer (Welch Allyn, USA) after 5 min of rest.
All of the patients were given a low lipid diet. Calculated kcal were based on ideal weight minus 200 kcal/day if overweight.
Results were expressed as mean ± Standard deviation (SD). Differences between initial vs. final values were compared with the Mann-Whitney U test. The normality hypothesis was tested using the Kolmogorov-Smirnov test. A p value of <0.05 was considered significant. All tests were performed with the SPSS ver. 23 statistical software program.
Kuupäevad
| Viimati kinnitatud: | 07/31/2018 |
| Esmalt esitatud: | 08/23/2018 |
| Hinnanguline registreerumine on esitatud: | 08/26/2018 |
| Esmalt postitatud: | 08/27/2018 |
| Viimane värskendus on esitatud: | 08/26/2018 |
| Viimati värskendus postitatud: | 08/27/2018 |
| Õppe tegelik alguskuupäev: | 12/31/2013 |
| Eeldatav esmane lõpetamise kuupäev: | 11/29/2014 |
| Eeldatav uuringu lõpetamise kuupäev: | 12/30/2014 |
Seisund või haigus
Sekkumine / ravi
Dietary Supplement: PC-300 tea
Drug: Bezafibrate
Faas
Käerühmad
| Arm | Sekkumine / ravi |
|---|---|
| Experimental: PC-300 tea Patients that received the Eryngium heterophyllum + Amphipterygium adstringens tea, one cup half an hour before eating. | Dietary Supplement: PC-300 tea Patients had to drink one cup of the tea half an hour before breakfast, main meal and dinner. |
| Active Comparator: Bezafibrate Patients that received fibrate (bezafibrate) 200 mg/day. | Drug: Bezafibrate Patients were prescribed 200 mg/day at night. |
Abikõlblikkuse kriteeriumid
| Õppimiseks sobivad vanused | 18 Years To 18 Years |
| Uuringuks kõlblikud sood | All |
| Võtab vastu tervislikke vabatahtlikke | Jah |
| Kriteeriumid | Inclusion Criteria: - Patients with hypertriglyceridemia, aged >18 years and with an educational level at least of primary school. Exclusion Criteria: - Patients with hepatic disease and those missing an appointment during the study. |
Tulemus
Esmased tulemusnäitajad
1. Triglycerides serum levels. [One month.]
